We are live on ! Find out more
KMED

KraneShares Emerging Markets Healthcare Index ETF

Delisted

KMED was delisted on the 18th of October, 2023.

1 hedge funds and large institutions have $225K invested in KraneShares Emerging Markets Healthcare Index ETF in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 (0)

12% less capital invested

Capital invested by funds: $256K → $225K (-$31K)

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$16.1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
1
Jane Street
New York
$225K +$16.1K +745 +7%

KMED Hedge Fund Activity: Q4 2018 in Review

1 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in KraneShares Emerging Markets Healthcare Index ETF (KMED) for Q4 2018, worth a combined $225K — down 12% from $256K a quarter earlier.

Fund positioning in KMED was balanced in Q4 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Jane Street, adding an estimated $16.1K.

  • 1 institutional investor held KraneShares Emerging Markets Healthcare Index ETF (KMED) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $225K of KraneShares Emerging Markets Healthcare Index ETF stock for Q4 2018, down 12% quarter-over-quarter.
  • 0 funds opened new KraneShares Emerging Markets Healthcare Index ETF positions in Q4 2018 and 0 closed out.
  • The largest KraneShares Emerging Markets Healthcare Index ETF buyer in Q4 2018 was Jane Street, an estimated $16.1K added.

Based on aggregated 13F filings for Q4 2018.